제 품 PRODUCT

Tell your doctor immediately if you (or your kid): might not be viewing as well as before beginning SABRIL; start to trip, bump into things, or are extra awkward than common sabril mechanism of action; are surprised by individuals or points can be found in front of you that appear to find out of no place; or if your baby is acting differently than regular.

The Vigabatrin REMS Program is needed by the FDA to make sure informed risk-benefit choices before launching therapy, and to ensure ideal use of vigabatrin while people are treated. It is not feasible for your healthcare provider to know when vision loss will take place.

It is suggested that your healthcare provider test your (or your child's) vision before or within 4 weeks after starting SABRIL and at least every 3 months throughout therapy until SABRIL is stopped. If you or your kid have any type of side impact that bothers you or that does not go away, inform your medical care supplier.

Tell your healthcare provider if you are expecting or mean to get expectant. If vision screening can not be done, your doctor might continue suggesting SABRIL, yet will not be able to look for any vision loss. If vision examinations are refrained from doing regularly, your healthcare provider may stop prescribing SABRIL for you (or your youngster).